CompletedNANCT07566728

ADAI - Home Care in Intelligent Environments Clinical Care Ecosystem for the Management of Home Digital Therapies Through the Use of Assistive Robots and Clinical Predictive Systems Based on Artificial Intelligence Systems

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo

Trial Details

Condition	Neurodegenerative Disease, Artificial Intelligence (AI), Mild Cognitive Impairment (MCI)
Intervention	CLINICAL INVESTIGATION WITH A MEDICAL DEVICE MARKED CE
Phase	NA
Status	Completed
Participants	23
Est. Completion	15 Oct 2025
Last Updated	5 May 2026

Primary Outcome

Mini Mental State Examination (MMSE) total score

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Age between 40 and 80 * Clinical Rating Scale (CDR) score \< 1 * Patients with moderate to mild cognitive impairment Exclusion Criteria: * Subjects with marked visual and hearing impairments that prevent proper understanding of the trial * Patients with impaired language comprehension * Patients with comorbid psychiatric disorders * Lack of consent to participate by signing the informed consent form

Trial Sites

Countries

Italy

View Registry Entry

Related Analysis

Completed Italian Trial Tests AI-Powered Robotic Home Care for Mild Cognitive Impairment — Early Results Show Promise for Digital Therapeutics

Italian researchers complete pioneering trial of AI-powered robotic home care system for mild cognitive impairment patients. The ADAI study tested humanoid robots delivering cognitive assessments in patients' homes, potentially transforming early dementia care delivery.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service